- Home
- PDSB vs XCUR Comparison
PDSB vs XCUR Comparison
Compare PDSB & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDSB | XCUR |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | United States | United States |
| Employees | 10 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 26.6M |
| IPO Year | 2015 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PDSB | XCUR |
|---|---|---|
| Price | $1.25 | $3.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 983.1K | 13.0K |
| Earning Date | 05-13-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.16 | ★ 83.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $3.10 |
| 52 Week High | $1.90 | $12.65 |
Technical Indicators
Market Signals| Indicator | PDSB | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 72.37 | 43.05 |
| Support Level | $1.18 | $3.82 |
| Resistance Level | $1.40 | $4.23 |
| Average True Range (ATR) | 0.15 | 0.20 |
| MACD | 0.06 | -0.04 |
| Stochastic Oscillator | 83.21 | 21.94 |
Price Performance
Historical ComparisonAbout PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.